Home LiteratureArticle Details
PMID: 30613598 Published · ppublish English Editorial Comment

Immunoscore-has it scored for colon cancer precision medicine?

Annals of translational medicine ·Vol. 6 ·No. Suppl 1 ·2018-11-00 ·Pages S23

Jorissen RN, Sakthianandeswaren A, Sieber OM

Abstract

暂无摘要

Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Jorissen Robert N
Systems Biology and Personalised Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. | Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Sakthianandeswaren Anuratha
Systems Biology and Personalised Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. | Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Sieber Oliver M
Systems Biology and Personalised Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. | Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. | Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia. | Department of Biochemistry & Molecular Biology, Monash University, Clayton, Victoria, Australia.
Conflict of Interest

Conflicts of Interest: The authors have no conflicts of interest to declare.

References (24)
24 references, click to expand
  1. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
    J Clin Oncol. 2004 Aug 15;22(16):3408-19 PMID: 15199089
  2. Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.
    Cancer Immun. 2004 Nov 25;4:14 PMID: 15563124
  3. Inflammation and prognosis in colorectal cancer.
    Eur J Cancer. 2005 Nov;41(17):2645-54 PMID: 16239109
  4. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Science. 2006 Sep 29;313(5795):1960-4 PMID: 17008531
  5. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
    J Clin Oncol. 2006 Nov 20;24(33):5313-27 PMID: 17060676
  6. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.
    Clin Cancer Res. 2009 Oct 15;15(20):6412-20 PMID: 19825961
  7. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
    J Clin Oncol. 2009 Dec 10;27(35):5944-51 PMID: 19858404
  8. Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability.
    PLoS One. 2010 Dec 31;5(12):e16012 PMID: 21209843
  9. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
    Cancer Treat Rev. 2012 Aug;38(5):451-66 PMID: 21945823
  10. Infiltration of colorectal carcinoma by S100+ dendritic cells and CD57+ lymphocytes as independent prognostic factors after radical surgical treatment.
    Anticancer Res. 2012 May;32(5):2129-32 PMID: 22593500
  11. Cancer classification using the Immunoscore: a worldwide task force.
    J Transl Med. 2012 Oct 03;10:205 PMID: 23034130
  12. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
    J Pathol. 2014 Jan;232(2):199-209 PMID: 24122236
  13. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.
    Br J Cancer. 2014 Mar 18;110(6):1595-605 PMID: 24504370
  14. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Gastroenterology. 2015 Jan;148(1):88-99 PMID: 25305506
  15. Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
    Immunity. 2016 Mar 15;44(3):698-711 PMID: 26982367
  16. Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
    J Natl Cancer Inst. 2016 May 12;108(8): PMID: 27172903
  17. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
    Sci Transl Med. 2016 Jul 6;8(346):346ra92 PMID: 27384348
  18. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
    Adv Anat Pathol. 2017 Nov;24(6):311-335 PMID: 28777143
  19. Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer.
    Diagn Pathol. 2017 Aug 29;12(1):65 PMID: 28851404
  20. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Gut. 2018 Jan 30;:null PMID: 29382774
  21. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    PLoS One. 2018 Apr 26;13(4):e0192744 PMID: 29698402
  22. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Lancet. 2018 May 26;391(10135):2128-2139 PMID: 29754777
  23. Lymphoid infiltration and prognosis in colorectal carcinoma.
    Br J Cancer. 1984 Mar;49(3):375-7 PMID: 6704315
  24. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.
    J Pathol. 1997 Jul;182(3):318-24 PMID: 9349235
Article Info
Journal
Annals of translational medicine
Abbr.
Ann Transl Med
ISSN
2305-5839
DOI
10.21037/atm.2018.09.29
Published
2018-11-00
Pages
S23
Language
English
Region
China
NLM ID
101617978
PMCID
PMC6291583
Corrections
CommentOn
PMID: 29754777
External Links
PubMed source DOI: 10.21037/atm.2018.09.29 PMC Full Text
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2